Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Merkel cell carcinoma is a rare cutaneous neuroendocrine carcinoma with a high rate of regional and distant metastasis and mortality. Here, we report a novel case of Merkel cell carcinoma which presented as a primary lesion to the left cheek with regional lymph node involvement and was treated with pembrolizumab and radiation. Widely metastatic disease eventually revealed on autopsy clinically mimicked immune-related organ insult leading to management with immunosuppressants. The patient also had a biopsy-confirmed immune-related cutaneous adverse event during admission. The case highlights a rare circumstance in which disease progression masqueraded as multiple immune-related end-organ adverse events. Contribution of on-target anti-PD-1 toxicity remains a possibility.

Cite

CITATION STYLE

APA

Saqlain, F., Shalhout, S. Z., Emerick, K. S., Neilan, T. G., Sharova, T., & Miller, D. M. (2020). Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events. Case Reports in Dermatological Medicine, 2020. https://doi.org/10.1155/2020/8890845

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free